Unknown

Dataset Information

0

TEM-184, a Novel TEM-Derived Extended-Spectrum ?-Lactamase with Enhanced Activity against Aztreonam.


ABSTRACT: TEM-184, a novel TEM-derived extended-spectrum ?-lactamase (ESBL), was isolated from an Escherichia coli ST354 clinical strain. Compared to TEM-1, TEM-184 contains the mutations Q6K, E104K, I127V, R164S, and M182T. Kinetic analysis of this enzyme revealed extended-spectrum activity against aztreonam in particular. TEM-184 was also susceptible to inhibitors, including clavulanic acid, tazobactam, and avibactam.

SUBMITTER: Piccirilli A 

PROVIDER: S-EPMC6125571 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.

Piccirilli Alessandra A   Perilli Mariagrazia M   Amicosante Gianfranco G   Conte Viola V   Tascini Carlo C   Rossolini Gian Maria GM   Giani Tommaso T  

Antimicrobial agents and chemotherapy 20180827 9


TEM-184, a novel TEM-derived extended-spectrum β-lactamase (ESBL), was isolated from an <i>Escherichia coli</i> ST354 clinical strain. Compared to TEM-1, TEM-184 contains the mutations Q6K, E104K, I127V, R164S, and M182T. Kinetic analysis of this enzyme revealed extended-spectrum activity against aztreonam in particular. TEM-184 was also susceptible to inhibitors, including clavulanic acid, tazobactam, and avibactam. ...[more]

Similar Datasets

| S-EPMC5744226 | biostudies-literature
| S-EPMC1196234 | biostudies-literature
| S-EPMC3053151 | biostudies-literature
| S-EPMC1563563 | biostudies-literature
| S-EPMC1068604 | biostudies-literature
| S-EPMC182605 | biostudies-literature
| S-EPMC3632918 | biostudies-literature
| S-EPMC1489774 | biostudies-literature
| S-EPMC192219 | biostudies-other
| S-EPMC105464 | biostudies-literature